| UniProt ID | HEY2_HUMAN | |
|---|---|---|
| UniProt AC | Q9UBP5 | |
| Protein Name | Hairy/enhancer-of-split related with YRPW motif protein 2 | |
| Gene Name | HEY2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 337 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Downstream effector of Notch signaling which may be required for cardiovascular development. Transcriptional repressor which binds preferentially to the canonical E box sequence 5'-CACGTG-3'. Represses transcription by the cardiac transcriptional activators GATA4 and GATA6.. | |
| Protein Sequence | MKRPCEETTSESDMDETIDVGSENNYSGQSTSSVIRLNSPTTTSQIMARKKRRGIIEKRRRDRINNSLSELRRLVPTAFEKQGSAKLEKAEILQMTVDHLKMLQATGGKGYFDAHALAMDFMSIGFRECLTEVARYLSSVEGLDSSDPLRVRLVSHLSTCATQREAAAMTSSMAHHHHPLHPHHWAAAFHHLPAALLQPNGLHASESTPCRLSTTSEVPPAHGSALLTATFAHADSALRMPSTGSVAPCVPPLSTSLLSLSATVHAAAAAATAAAHSFPLSFAGAFPMLPPNAAAAVAAATAISPPLSVSATSSPQQTSSGTNNKPYRPWGTEVGAF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 39 | Phosphorylation | SSVIRLNSPTTTSQI CCEEECCCCCCHHHH | 28.37 | 28857561 | |
| 41 | Phosphorylation | VIRLNSPTTTSQIMA EEECCCCCCHHHHHH | 42.39 | 23403867 | |
| 42 | Phosphorylation | IRLNSPTTTSQIMAR EECCCCCCHHHHHHH | 28.03 | 29449344 | |
| 43 | Phosphorylation | RLNSPTTTSQIMARK ECCCCCCHHHHHHHH | 22.55 | 27251275 | |
| 44 | Phosphorylation | LNSPTTTSQIMARKK CCCCCCHHHHHHHHH | 18.67 | 27251275 | |
| 58 | Acetylation | KRRGIIEKRRRDRIN HHHCHHHHHHHHHHH | 40.57 | 30589153 | |
| 96 | Phosphorylation | KAEILQMTVDHLKML HHHHHHHHHHHHHHH | 15.15 | - | |
| 131 | Phosphorylation | IGFRECLTEVARYLS HCHHHHHHHHHHHHH | 39.82 | - | |
| 138 | Phosphorylation | TEVARYLSSVEGLDS HHHHHHHHHCCCCCC | 24.33 | - | |
| 139 | Phosphorylation | EVARYLSSVEGLDSS HHHHHHHHCCCCCCC | 22.92 | - | |
| 145 | Phosphorylation | SSVEGLDSSDPLRVR HHCCCCCCCCHHHHH | 41.50 | - | |
| 205 | Phosphorylation | QPNGLHASESTPCRL CCCCCCCCCCCCCCE | 22.72 | - | |
| 207 | Phosphorylation | NGLHASESTPCRLST CCCCCCCCCCCCEEC | 34.84 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HEY2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HEY2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SIR1_HUMAN | SIRT1 | physical | 12535671 | |
| HDAC9_HUMAN | HDAC9 | physical | 11486045 | |
| NCOR1_HUMAN | NCOR1 | physical | 11486045 | |
| SIN3A_HUMAN | SIN3A | physical | 11486045 | |
| HDAC1_HUMAN | HDAC1 | physical | 11486045 | |
| HES1_HUMAN | HES1 | physical | 11486045 | |
| FBW1A_HUMAN | BTRC | physical | 17217622 | |
| NOTC1_HUMAN | NOTCH1 | genetic | 18239137 | |
| HD_HUMAN | HTT | physical | 23275563 | |
| SE1L1_HUMAN | SEL1L | physical | 24366871 | |
| SYVN1_HUMAN | SYVN1 | physical | 24366871 | |
| HEY1_HUMAN | HEY1 | physical | 24366871 | |
| DERL2_HUMAN | DERL2 | physical | 24366871 | |
| HEY1_HUMAN | HEY1 | physical | 26186194 | |
| CARM1_HUMAN | CARM1 | physical | 26186194 | |
| ARL10_HUMAN | ARL10 | physical | 26186194 | |
| IST1_HUMAN | IST1 | physical | 26186194 | |
| FBSP1_HUMAN | FBXO45 | physical | 26068074 | |
| HEY1_HUMAN | HEY1 | physical | 28514442 | |
| ARL10_HUMAN | ARL10 | physical | 28514442 | |
| CHM1A_HUMAN | CHMP1A | physical | 28514442 | |
| IST1_HUMAN | IST1 | physical | 28514442 | |
| CARM1_HUMAN | CARM1 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39, AND MASSSPECTROMETRY. | |